The Molecular Analysis for Precision Oncology Congress 2026 will take place from 10 to 11 September in London, UK, bringing together leading experts in oncology, molecular diagnostics, and precision medicine for two days of high-level exchange, collaboration, and innovation.

The 6th iPSC Drug Development Summit is the only meeting exclusively focused on advancing iPSC-based cell therapies, end-to-end.

This year, NLSDays will shine a light on the latest trends shaping the global life science industry while continuing to elevate Nordic success stories.

The 8th RAS-Targeted Drug Development Summit is the industry's only forum dedicated exclusively to translating RAS therapies from early discovery through clinical development.

Entering its 6th year, Advanced Therapies Europe 2026 remains an intentionally intimate gathering for senior decision-makers, designed to deliver real impact with each and every conversation.

This year's Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot, enhancing precision, speed, and safety in patient care. Discover AI in action, from diagnosis to delivery, through hands-on sessions, live demonstrations, and immersive learning.

CPHI Korea is a dynamic meeting place where pharmaceutical suppliers, purchasers and decision makers get together for three days of uninterrupted business.

Returning for 2026, the 4th ADC Toxicity Summit is the only dedicated industry forum exclusively focused on preventing, predicting, and mitigating ADC toxicities across preclinical and clinical development.

As oligonucleotide therapeutics expand across ASOs, siRNA, gRNA, and increasingly complex conjugates, the field is entering a new phase of clinical and commercial maturity.

The 3rd Lab Ops & Facility Management for Biopharma West Summit will unite 70+ senior lab operations and facilities professionals from leading biotech and pharma organizations to discuss how to run smarter, more resilient laboratories.

Now in its 18th year, the Bioprocessing Summit unites a global community of scientists, engineers, and executives driving innovation and digitalization across process development, scale-up, quality, and analytics for biologics, antibodies, cell and gene, RNA, and oligonucleotide therapies.

Join them this July 29-30 as they unite 210+ preclinical and translational leaders, and ensure you're equipped with the latest tumor modeling strategies to de-risk your own oncology pipelines before the move to the clinic.

Returning to Boston, the 5th In Vivo Cell Engineering & Gene Editing Summit is the only meeting dedicated entirely to advancing targeted in vivo delivery, early clinical validation, and global development strategy.

Through hands-on workshops, technical debates, and collaborative networking, this summit gives you the rare opportunity to shape the linker and conjugation strategies that will define the next decade of ADC development.

Over three focused days, gain practical insight into how leading organizations are solving the scientific, clinical, manufacturing, and supply challenges that define success in this space.

With science innovation at the core of the momentum, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world’s flagship meeting for the mRNA community.

The 6th edition of the ground-breaking series of ICLE Conferences will gather the brightest minds in lymphocyte engineering and redefine the boundaries of immune-gene and cell therapy.

CRYO2026 heads to Seattle, the home of Microsoft, Amazon, Boeing, Starbucks, (and grunge music!), as well as a thriving cryobiology hub located at the University of Washington, Seattle University, the Allen Institute, Fred Hutchinson Cancer Center, and more.

Bringing together Process Development, Analytical Development, QC, and MSAT leaders from early clinical to commercial stage, this is the only industry-led event dedicated exclusively to the process development and automation challenges determining whether your therapy reaches patients.

AAPS, the convener of the pharmaceutical industry, brings scientists working in pharmaceutical analysis and bioanalysis together in the Summer Scientific Forum.

Join the PDA Advanced Therapy Medicinal Products Conference 2026, taking place on 25–26 June 2026 under the theme “Innovation without Borders: Managing Global Expectations in the Age of Intelligence.”

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

The Generis European Pharma Outsourcing Summit sets the standard on how the industry should connect and exchange ideas. Their executive pharma conference is tailored to provide executives from pharmaceutical companies with the latest innovations, strategic insights, and best practices.

The DIA Global Annual Meeting is where life sciences professionals from industry, regulatory agencies, patients, and academia come together to drive breakthroughs in healthcare — advancing science, policy, and patient outcomes worldwide.

The Symposium brings together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field.

The World Orphan Drug Congress USA brings together the leading pharmaceutical and biotechnology companies, government and regulators, patient advocates, payers, investors, and solution providers.

The 5th World ADC Summit South Korea (previously World ADC Asia) is returning to provide you with the most comprehensive platform for South Korea’s rapidly growing ADC community.

Join SAE Media Group’s renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.

With the meeting fast approaching, get ready to unite with agbiotech leaders at BASF, UPL, GrowMark, Syngenta, Robigo, Kula Bio and Indigo Ag to formulate innovative and credible agbiologicals that meet the needs of the complete agbiotech ecosystem.